GRIA2 Antikörper (AA 278-292)
Kurzübersicht für GRIA2 Antikörper (AA 278-292) (ABIN1742379)
Target
Alle GRIA2 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 278-292
-
Spezifität
- Specific for GluA 2.
-
Aufreinigung
- Affinity purified with the immunogen. Rabbit serum albumin was added for stabilization.
-
Immunogen
- Synthetic peptide (aa 278-292 of rat GluA 2, unprocessed precursor) coupled to KLH via a C-terminal cysteine.
-
-
-
-
Applikationshinweise
-
WB: 1 : 1000 (AP staining)
ICC: not tested yet
IHC: not tested yet -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- For reconstitution add 50 µL H2O to get a 1mg/ml solution of antibody in PBS. Then aliquot and store at -20 °C until use.
-
Buffer
- PBS
-
Handhabung
- Affinity purified antibodies are less robust than antisera, since protease inhibitors are also removed during purification. Hence, storage at 4 °C for prolonged periods (i.e. several weeks), is not recommended.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Unlabeled lyophilized antibodies are stable in this form without loss of quality at ambient temperatures for several weeks or even months. They can be stored at 4°C for several years. Lyophilized antibodies must not be stored in the freezer, they may be destroyed!
-
-
-
: "Developmental switch in the kinase dependency of long-term potentiation depends on expression of GluA4 subunit-containing AMPA receptors." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 111, Issue 11, pp. 4321-6, (2014) (PubMed).
-
: "Developmental switch in the kinase dependency of long-term potentiation depends on expression of GluA4 subunit-containing AMPA receptors." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 111, Issue 11, pp. 4321-6, (2014) (PubMed).
-
- GRIA2 (Glutamate Receptor, Ionotropic, AMPA 2 (GRIA2))
-
Andere Bezeichnung
- GluA 2
-
Hintergrund
- Synonyms: AMPA 2, GluR 2
-
Pathways
- PI3K-Akt Signalweg
Target
-